KHK-2898
Based on 1 Customer Validation
KHK-2898 is a monoclonal antibody targeting CD98, which binds to the extracellular domain of CD98 on the tumor cell membrane in a non-covalent antigen-specific mode. KHK-2898 can disrupt the heterodimeric complex formed by CD98 with LAT1 and xCT light chains, reduce the amino acid uptake capacity of tumor cells, block the PI3K/AKT/mTOR proliferative signaling cascade, and mediate antibody-dependent cytotoxicity. KHK-2898 can be used for cancer-related research. The isotype control of KHK-2898 can be found in Human IgG1 kappa, Isotype Control (HY-P99001).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 97.16%
- Masse moléculaire:144.943 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Human IgG1 kappa
Human
|
Akt |
PI3K |
mTOR |
KHK-2898 recognizes the extracellular domain of CD98hc on the surface of tumor cells in a non-covalent antigen-binding manner, which can prevent CD98hc from forming heterodimers with LAT1 and xCT, weaken the tumor cells' ability to take up neutral amino acids and cystine, thereby inhibiting the PI3K/AKT/mTOR proliferative signaling pathway. At the same time, it can trigger antibody-dependent cytotoxicity in tumor cells with high CD98hc expression[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
AAH01061
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Appearance Liquid
-
Masse moléculaire 144.943 kDa
-
Color Colorless to light yellow
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KHK-2898 Related Classifications
HY-P990610 Related Classifications
Powered by Bioz
- KHK-2898
- KHK2898
- KHK 2898
- Akt
- mTOR
- PI3K
- monoclonal antibody targeting CD98hc (SLC3A2)
- non-covalent antigen-specific binding
- disrupt CD98hc-LAT1 heterodimer
- disrupt CD98hc-xCT heterodimer
- inhibit amino acid uptake
- block PI3K/AKT/mTOR signaling
- trigger antibody-dependent cellular cytotoxicity (ADCC)
- head and neck squamous cell carcinoma (HNSCC)
- glioblastoma
- colon adenocarcinoma
- pancreatic ductal adenocarcinoma (PDAC)
- non-small cell lung cancer (NSCLC)
- breast cancer
- gastric adenocarcinoma
- tumor xenograft murine model
- Inhibitor
- inhibitor
- inhibit